Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 1, 2012

 

 

RPX Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35146   26-2990113

(State or other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

One Market Plaza

Suite 800

San Francisco, CA 94105

(Address of principal executive offices, including zip code)

(866) 779-7641

(Registrant’s telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

On May 1, 2012, RPX Corporation issued a press release announcing its financial results for the quarter ended March 31, 2012. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Press release issued by RPX Corporation dated May 1, 2012


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

RPX Corporation

By:

  /s/ MARTIN E. ROBERTS
 

Martin E. Roberts

General Counsel

Dated: May 1, 2012

Press Release

Exhibit 99.1

 

LOGO

RPX Announces First Quarter 2012 Financial Results

SAN FRANCISCO – May 1, 2012 – RPX Corporation (NASDAQ: RPXC), a leading provider of patent risk solutions, offering defensive buying, acquisition syndications, patent intelligence and advisory services, today announced its financial results for the first quarter ended March 31, 2012.

Financial Highlights

 

   

Revenue for the first quarter of fiscal 2012 totaled $43.8 million, up 28% from the prior year period

 

   

GAAP net income for the first quarter of fiscal 2012 was $8.1 million or $0.15 per pro forma diluted share[1]

 

   

Non-GAAP net income for the first quarter of fiscal 2012 was $10.0 million or $0.19 per pro forma diluted share[1]

“In the first quarter, we continued to execute on our plan to expand our client network and patent portfolio, while further demonstrating our syndicated acquisition capabilities and developing our future products and services,” said John Amster, CEO of RPX Corporation. “As of the end of the first quarter, our client network totaled 116 clients and we had deployed approximately $385 million to purchase patents and patent rights on behalf of our clients. During the quarter, we also announced our largest syndicated acquisition to date, the Altitude Capital transaction. We believe this transaction creates significant value for current and future clients while furthering our vision for a more rational marketplace.”

Summary Results

Revenue for the first quarter increased 28% to $43.8 million, compared to $34.4 million in the first quarter of 2011.

Net acquisition spend during the quarter totaled $13.4 million, and included seven new acquisitions of patent assets, in addition to the exercise of previously negotiated options to acquire licenses for new clients.

GAAP net income for the quarter was $8.1 million or $0.15 per diluted share, compared to $6.7 million or $0.14 per diluted share in the first quarter of 2011. Net income was $0.15 per pro forma diluted share[1] in the first quarter, compared to $0.17 per pro forma diluted share[1] in the first quarter of 2011.

Non-GAAP net income for the quarter, which excludes stock-based compensation and the amortization of acquired intangibles (in each case, net of tax), was $10.0 million or $0.19 per pro forma diluted share[1] , compared to $7.7 million or $0.20 per pro forma diluted share[1] in the first quarter of 2011.

As of March 31, 2012, RPX had cash, cash equivalents and short-term investments of $252.1 million.

 

 

[1] 

Pro forma diluted share computed to give effect to the shares of restricted stock outstanding as of the original date of issuance and the conversion of the Company’s redeemable convertible preferred stock into common stock using the as-if converted method as though the conversion had occurred as of January 1, 2011 or the original issuance, if later.


RPX Announces First Quarter 2012 Financial Results

  Page |  2

 

Business Outlook

This outlook reflects the Company’s current and preliminary view and may be subject to change. Please see the paragraph regarding “Forward-Looking Statements” at the end of this news release. The Company provided the following business outlook for the second quarter and full year 2012:

 

   

Second Quarter 2012

 

Full Year 2012

Revenue

  $50.7 – $51.3 Million   $193 – $203 Million

Non-GAAP Cost of Revenues as a Percentage of Revenue

  —     40% – 42%

Non-GAAP SG&A

 

—  

  $45 – $49 Million

Non-GAAP Net Income

  $11.0 – $11.8 Million   $42 – $48 Million

Non-GAAP Effective Tax Rate

  36%   36%

Diluted Shares Outstanding (Pro Forma Weighted Average)

  53.0 Million   53.5 Million

Net Acquisition Spend

 

—  

  $110 – $120 Million

The above outlook is forward-looking. Actual results may differ materially. Please refer to the information under the caption “Use of Non-GAAP Financial Information” below.

Conference Call

RPX management will host a conference call and live webcast for analysts and investors at 2:00 p.m. PDT/5:00 p.m. EDT on May 1, 2012. Parties in the United States and Canada can access the call by dialing 1-877-941-1427, using conference code 4528975. International parties can access the call by dialing 1-480-629-9664, using conference code 4528975.

RPX will offer a live webcast of the conference call which can be accessed from the “Investor Relations” section of the Company’s website at www.rpxcorp.com. The webcast will be archived there for a period of 30 days. An audio replay of the conference call will also be available two hours after the call and will be available for 30 days. To hear the replay, parties in the United States and Canada should call 1-800-406-7325 and enter conference code 4528975. International parties should call 1-303-590-3030 and enter conference code 4528975.

About RPX Corporation

RPX Corporation (NASDAQ: RPXC) is a leading provider of patent risk solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services. Since its founding in 2008, RPX has introduced efficiency to the patent market by providing a rational alternative to litigation. The San Francisco-based company’s pioneering approach combines principal capital, deep patent expertise, and client contributions to generate enhanced patent buying power. By acquiring patents, RPX helps to mitigate and manage patent risk for its growing client network.


RPX Announces First Quarter 2012 Financial Results

  Page |  3

 

Use of Non-GAAP Financial Information

This news release dated May 1, 2012 contains non-GAAP financial measures. Tables are provided in this news release that reconcile the non-GAAP financial measures to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures include non-GAAP cost of revenues, non-GAAP selling, general and administrative expense, non-GAAP net income, and non-GAAP earnings per share.

To supplement the Company’s consolidated financial statements presented on a GAAP basis, management believes that these non-GAAP measures provide useful information about the Company’s core operating results and thus are appropriate to enhance the overall understanding of the Company’s past financial performance and its prospects for the future. Management is excluding from its non-GAAP operating results stock-based compensation expenses (inclusive of related employer payroll taxes) and the amortization of acquired intangible assets. Management uses these non-GAAP measures to evaluate the Company’s financial results, and believes investors wish to exclude the effects of such items in comparing our financial performance with that of other companies. The adjustments to the Company’s GAAP results are made with the intent of providing both management and investors a more complete understanding of the Company’s underlying operational results, trends and performance. The presentation of additional information is not meant to be considered in isolation or as a substitute for or superior to financial results determined in accordance with GAAP.

Forward-Looking Statements

This news release and its attachments contain forward-looking statements within the meaning of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements regarding RPX’s future financial performance as well as any statements regarding the Company’s strategic and operational plans. The Company’s actual results may differ materially from those anticipated in these forward-looking statements. Factors that may contribute to such differences include, among others, the Company’s ability to maintain an adequate rate of growth, the impact of the current economic climate on the Company’s business, the Company’s ability to effectively manage its growth, and the Company’s ability to attract new clients and retain existing clients. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “will,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” and similar expressions or variations intended to identify forward-looking statements. More information about potential factors that could affect the Company’s business and financial results is contained in the Company’s most recent annual report on Form 10-K, its quarterly reports on Form 10-Q, and the Company’s other filings with the SEC. The Company does not intend, and undertakes no duty, to update any forward-looking statements to reflect future events or circumstances.

#    #    #


RPX Announces First Quarter 2012 Financial Results

  Page |  4

 

Contacts:

 

Investor Relations    Media Relations

Cynthia Hiponia

   Kaustuva Das

The Blueshirt Group

   RPX Corporation

+1-415-418-2563

   +1-415-529-3105

ir@rpxcorp.com

   media@rpxcorp.com


RPX Announces First Quarter 2012 Financial Results

  Page |  5

 

RPX Corporation

Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended March 31,  
     2012     2011  

Revenue

   $ 43,849      $ 34,390   

Cost of revenue

     18,017        13,665   

Selling, general and administrative expenses

     13,223        8,110   

(Gain) on sale of patent assets, net

     (177     —     
  

 

 

   

 

 

 

Operating income

     12,786        12,615   

Interest income

     51        26   

Interest and other expense, net

     (71     (399
  

 

 

   

 

 

 

Income before provision for income taxes

     12,766        12,242   

Provision for income taxes

     4,685        5,547   
  

 

 

   

 

 

 

Net income

   $ 8,081      $ 6,695   
  

 

 

   

 

 

 

Net income available to common stockholders:

    

Basic

   $ 7,840      $ 1,046   
  

 

 

   

 

 

 

Diluted

   $ 7,853      $ 1,249   
  

 

 

   

 

 

 

Net income per common share:

    

Basic

   $ 0.16      $ 0.14   
  

 

 

   

 

 

 

Diluted

   $ 0.15      $ 0.14   
  

 

 

   

 

 

 

Weighted-average shares used in computing net income per common share:

    

Basic

     48,308        7,221   
  

 

 

   

 

 

 

Diluted

     51,226        9,036   
  

 

 

   

 

 

 


RPX Announces First Quarter 2012 Financial Results

  Page |  6

 

RPX Corporation

Consolidated Balance Sheets

(in thousands)

(unaudited)

 

     March 31,
2012
    December 31,
2011
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 101,569      $ 106,749   

Short-term investments

     150,535        126,976   

Restricted cash

     —          500   

Accounts receivable

     6,497        16,160   

Prepaid expenses and other current assets

     14,771        12,124   

Deferred tax assets

     5,192        5,192   
  

 

 

   

 

 

 

Total current assets

     278,564        267,701   

Patent assets, net

     159,047        163,352   

Property and equipment, net

     3,138        2,317   

Goodwill and intangible assets, net

     3,284        3,512   

Restricted cash, less current portion

     147        147   

Deferred tax assets, less current portion

     300        300   

Other assets

     318        665   
  

 

 

   

 

 

 

Total assets

   $ 444,798      $ 437,994   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity

    

Current liabilities:

    

Accounts payable

   $ 783      $ 821   

Accrued liabilities

     3,522        7,762   

Deferred revenue

     97,432        96,513   

Deferred payment obligations

     1,869        5,056   

Other current liabilities

     2,029        2,182   
  

 

 

   

 

 

 

Total current liabilities

     105,635        112,334   

Deferred revenue, less current portion

     8,369        11,762   

Deferred tax liabilities

     14,695        14,695   

Other liabilities

     49        119   
  

 

 

   

 

 

 

Total liabilities

     128,748        138,910   
  

 

 

   

 

 

 

Common stock

     5        5   

Additional paid-in capital

     268,187        259,315   

Retained earnings

     47,868        39,787   

Accumulated other comprehensive loss

     (10     (23
  

 

 

   

 

 

 

Total stockholders’ equity

     316,050        299,084   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 444,798      $ 437,994   
  

 

 

   

 

 

 


RPX Announces First Quarter 2012 Financial Results

  Page |  7

 

RPX Corporation

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

     Three Months Ended March 31,  
     2012     2011  

Cash flows from operating activities

    

Net income

   $ 8,081      $ 6,695   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     18,125        13,667   

Stock-based compensation

     2,491        1,048   

Excess tax benefit from stock-based compensation

     (4,494     —     

Imputed interest on deferred payment obligations

     63        263   

Gain on sale of patent assets

     (177     —     

Amortization of premium on investments

     1,020        68   

Deferred taxes

     —          (11

Other

     (13     —     

Changes in assets and liabilities:

    

Accounts receivable

     9,663        11,887   

Prepaid expenses and other assets

     (1,208     1,582   

Accounts payable

     (38     (18

Accrued and other liabilities

     (5,049     (5,740

Deferred revenue

     (2,474     10,203   
  

 

 

   

 

 

 

Net cash provided by operating activities

     25,990        39,644   
  

 

 

   

 

 

 

Cash flows from investing activities

    

Purchases of investments classified as available-for-sale

     (75,255     (15,100

Maturities and sale of investments classified as available-for-sale

     53,844        —     

Decrease in restricted cash

     500        —     

Purchases of intangible assets

     (33     —     

Purchases of property and equipment

     (882     (386

Acquisitions of patent assets

     (12,515     (19,139

Proceeds from sale of patent assets

     200        —     
  

 

 

   

 

 

 

Net cash used in investing activities

     (34,141     (34,625
  

 

 

   

 

 

 

Cash flows from financing activities

    

Repayments of principal on deferred payment obligations

     (3,250     (9,288

Initial public offering-related costs

     —          (762

Proceeds from exercise of stock options and other common stock issuances

     1,727        228   

Excess tax benefit from stock-based compensation

     4,494        —     
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     2,971        (9,822
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (5,180     (4,803

Cash and cash equivalents at beginning of period

     106,749        46,656   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 101,569      $ 41,853   
  

 

 

   

 

 

 


RPX Announces First Quarter 2012 Financial Results

  Page |  8

 

RPX Corporation

Reconciliation of Pro Forma Net Income Per Share

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended
March 31,
 
     2012      2011  

Net income

   $ 8,081       $ 6,695   
  

 

 

    

 

 

 

Pro forma net income per share[1]:

     

Basic

   $ 0.16       $ 0.18   
  

 

 

    

 

 

 

Diluted

   $ 0.15       $ 0.17   
  

 

 

    

 

 

 

Shares used in computing pro forma net income per share:

     

Basic:

     

Basic weighted-average common shares

     48,308         7,221   

Add: Assumed conversion of redeemable convertible preferred shares

     —           26,230   

Add: Restricted stock

     1,483         3,980   
  

 

 

    

 

 

 

Shares used in computing pro forma basic net income per share

     49,791         37,431   
  

 

 

    

 

 

 

Diluted:

     

Diluted weighted-average common shares

     51,226         9,036   

Add: Assumed conversion of redeemable convertible preferred shares

     —           26,230   

Add: Restricted stock

     1,483         3,980   
  

 

 

    

 

 

 

Shares used in computing pro forma diluted net income per share

     52,709         39,246   
  

 

 

    

 

 

 

 

[1] 

Pro forma basic and diluted net income per share were computed to give effect to the shares of restricted stock outstanding as of the original date of issuance and the conversion of the Company’s redeemable convertible preferred stock into common stock using the as-if converted method as though the conversion had occurred as of January 1, 2011 or the original issuance, if later.


RPX Announces First Quarter 2012 Financial Results

  Page |  9

 

RPX Corporation

Reconciliation of GAAP to Non-GAAP Net Income Per Share

(in thousands)

(unaudited)

 

     Three Months Ended March 31,  
     2012     2011  

Net income

   $ 8,081      $ 6,695   

Stock-based compensation[1]

     2,673        1,048   

Amortization of acquired intangible assets [2]

     150        —     

Income tax adjustments [3]

     (888     —     
  

 

 

   

 

 

 

Non-GAAP net income

   $ 10,016      $ 7,743   
  

 

 

   

 

 

 

Pro forma non-GAAP net income per share:

    

Basic

   $ 0.20      $ 0.21   
  

 

 

   

 

 

 

Diluted

   $ 0.19      $ 0.20   
  

 

 

   

 

 

 

Pro forma weighted-average shares:

    

Basic

     49,791        37,431   
  

 

 

   

 

 

 

Diluted

     52,709        39,246   
  

 

 

   

 

 

 

RPX Corporation

Reconciliation of GAAP to Non-GAAP Cost of Revenue

(in thousands)

(unaudited)

 

     Three Months Ended March 31,  
     2012     2011  

Cost of revenue

   $ 18,017      $ 13,665   

Amortization of acquired intangible assets[2]

     (56     —     
  

 

 

   

 

 

 

Non-GAAP cost of revenue

   $ 17,961      $ 13,665   
  

 

 

   

 

 

 

RPX Corporation

Reconciliation of GAAP to Non-GAAP Selling, General and Administrative Expenses

(in thousands)

(unaudited)

 

     Three Months Ended March 31,  
     2012     2011  

Selling, general and administrative expenses

   $ 13,223      $ 8,110   

Stock-based compensation[1]

     (2,673     (1,048

Amortization of acquired intangible assets[2]

     (94     —     
  

 

 

   

 

 

 

Non-GAAP selling, general and administrative expenses

   $ 10,456      $ 7,062   
  

 

 

   

 

 

 

 

[1] 

RPX excludes stock-based compensation and related employer payroll taxes from its non-GAAP financial measures.

[2] 

RPX excludes amortization expense related to intangible assets (other than patents) acquired in conjunction with the acquisition of businesses from its non-GAAP financial measures.

[3] 

Amount reflects income taxes associated with the above noted non-GAAP exclusions.


RPX Announces First Quarter 2012 Financial Results

  Page |  10

 

RPX Corporation

Additional Metrics

($ in thousands)

(unaudited)

 

     As of and for the Three Months Ended March 31,  
      2012      2011  

Operating Metrics

     

Number of clients at quarter end

     116         81   

Net additions in quarter

     4         9   

Trailing four quarters

     35         42   

Gross acquisition spend in quarter

   $ 13,380       $ 19,429   

Trailing four quarters

   $ 97,746       $ 80,053   

Net acquisition spend in quarter

   $ 13,380       $ 19,429   

Trailing four quarters

   $ 93,121       $ 70,536   

Full time equivalent headcount at quarter end

     125         73   

Financial Metrics

     

Subscription revenue

   $ 43,839       $ 34,390   

Other revenue

     10         —     
  

 

 

    

 

 

 

Revenue

   $ 43,849       $ 34,390   
  

 

 

    

 

 

 

Cash, cash equivalents and short-term investments

   $ 252,104       $ 57,149   

Deferred revenue, current and noncurrent

   $ 105,801       $ 92,763